US 10815305
Methods of treating inflammatory conditions
granted A61KA61K2039/507A61K38/1793
Quick answer
US patent 10815305 (Methods of treating inflammatory conditions) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 44
- CPC classes
- A61K, A61K2039/507, A61K38/1793, A61K39/3955, A61K45/06